2m 2m 2m 2m 2m 2m 2m
Inhibrx Bio (INBX)
NASDAQ
$109.43+$0.16 (+0.15%)
Price as of Sep 11, 2026 7:30 PM EDT- $1.6BMarket Cap
- 297.06%1-Year Change
- BiotechnologyIndustry
Inhibrx Bio (INBX)
$109.43+$0.16 (+0.15%)
Earnings Score
Valuation | INBX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -0 | ||
Low Earnings Volatility | N/A |
Momentum Score
Valuation | INBX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 10.39% | ||
12-Month Momentum | 245.73% | ||
3-Month Risk Adjusted Momentum | 48.45% | ||
12-Month Risk Adjusted Momentum | 192.39% |
True Yield
Valuation | INBX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.13% |
Financial Health Score
Valuation | INBX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 1 |